期刊文献+

环氧合酶-2蛋白在结肠疾病中的表达 被引量:38

Expression of Cyclooxygenase-2 Protein in Colon Diseases
下载PDF
导出
摘要 背景:长期使用非甾体类抗炎药(NSAIDs)的患者结肠癌发病率明显下降,NSAIDs能抑制环氧合酶(COX),COX-2在结肠癌的发生过程中起有作用。目的:调查COX-2在结肠病变中的表达。方法:用免疫组化方法检测正常和病变结肠组织中COX-2和COX-1蛋白的表达。结果:COX-2蛋白在正常结肠组织中呈低强度表达,在炎症性肠病(IBD)、结肠腺瘤和结肠癌组织中表达强度明显增高。COX-1蛋白在正常结肠粘膜、IBD、结肠腺瘤和结肠癌组织的上皮细胞和间质细胞中均呈低强度表达。结论:COX-2在结肠肿瘤和IBD的发生中可能起有某种作用。 Background/Aims: Long-term administration of nonsteroidal anti-inflammatory drugs (NSAIDs) may reduce the incidence of colon adenocarcinoma by targeting cyclooxygenase (COX) activity. The inducible COX-2 may play a role in colon carcinogenesis. The purpose of this study was to investigate the expression of COX-2 protein in normal and diseased coion. Methods: COX-2 and COX-1 protein expression were examined by immunohistochemistry in tissue spesimens of normal and diseased colon.Results: COX-2 protein was strongly expressed in the epithelial cells of inflammatory bowel disease (IBD), sporadic colonic adenomas and colon adenocarcinomas, while detectable in low level in normal colon. COX-1 protein expression was restricted to some interstitial cells and rarely seen in the epithelial cells of normal and diseased colon. Conclusions: Aberrant COX-2 expression may contribute to the development of IBD and colon carcinogenesis.
出处 《胃肠病学》 2000年第3期158-160,共3页 Chinese Journal of Gastroenterology
关键词 过氧化物合酶 消炎药 炎性肠疾病 结肠肿瘤 Prostaglandin-Endoperoxide Synthase Anti-Inflammatory Agents, Non-Steroidal Inflammatory Bowel Diseases, Colonic Neoplasms, Immunohistochemistry
  • 相关文献

参考文献14

  • 1Williams CS, DuBois RN.Prostaglandin endoperoxide synthase: why two isoforms? Am J Physiol,1996, 270 (3 Pt 1):G393~400.
  • 2Giardiello FM, Offerhaus GJ, DuBois RN. The role of nonsteroidal anti-inflammatorydrugs in colorectal cancer prevention. Eur J Cancer, 1995,31A: 1071~1076.
  • 3Cohn SM, Schloemann S, Tessner T, Seibert K,Stenson WF. Crypt stem cell survival inthe mouse intestinal epithelium is regulated by prostaglandins synthesized throughcyclooxygenase-1.J Clin Invest, 1997, 99: 1367~1379.
  • 4Eberhart CE, Dubois RN. Eicosanoids and the gastrointestinal tract.Gastroenterology, 1995, 109:285~301.
  • 5Singer Ⅱ, Kawka DW, Schloemann S, Tessner T,Riehl T, Stenson WF. Cyclooxygenase 2is induced in colonic epithelial cells in inflammatory bowel disease. Gastroenterology,1998, 115: 297~306.
  • 6Sharon P, Stenson WF. Enhanced synthesis of leukotriene B4 by colonic mucosa ininflammatory bowel disease. Gastroenterology, 1984, 86:453 ~460.
  • 7Masferrer JL, Reddy ST, Zweifel BS, Seibert K,Needleman P, Gilbert RS, HerschmanHR. In vivo glucocorticoids regulate cyclooxygenase-2 but not cyclooxygenase-1 inperitoneal macrophages. J Pharmacol Exp Ther, 1994, 270: 1340~1344.
  • 8Izutani R, Loh EY, Reinecker H, et al. Increased expression of interleukin-8 mRNAin ulcerative colitis and Crohn's disease mucosa and epithelial cell. Inflammatory BowelDis, 1995, 1: 37~47.
  • 9Reuter BK, Asfaha S, Buret A, Sharkey KA,Wallace JL. Exacerbation ofinflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. JClin Invest, 1996, 98:2076~2085.
  • 10Oshima M, Dinchuk JE, Kargman SL, Oshima H,Hancock B, Kwong E, Trzaskos JM, EvansJF,Taketo MM. Suppression of intestinal polyposis in Apc delta716 knockout mice byinhibition of cyclooxygenase 2 (COX-2). Cell, 1996, 87: 803~809.

同被引文献364

引证文献38

二级引证文献224

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部